Dr. Dorinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Circle
#203
Chapel Hill, NC 27517Phone+1 984-974-5703
Summary
- Dr. Paul Dorinsky is a pulmonologist in Chapel Hill, NC. He received his medical degree from The Ohio State University College of Medicine and has been in practice 39 years. He specializes in a asthma and COPD
Education & Training
- Ohio State University HospitalResidency, Internal Medicine, 1979 - 1981
- Ohio State University HospitalInternship, Internal Medicine, 1978 - 1979
- Ohio State University College of MedicineClass of 1978
Certifications & Licensure
- NC State Medical License 2023 - 2025
- PA State Medical License 2009 - 2012
- CT State Medical License 1998 - 1999
- OH State Medical License 1980 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects Start of enrollment: 2017 Apr 17
- Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler® Start of enrollment: 2016 Aug 09
- A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 Start of enrollment: 2017 Oct 17
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsPredictive modeling of COPD exacerbation rates using baseline risk factors.Dave Singh, John R Hurst, Fernando J Martinez, Klaus F Rabe, Mona Bafadhel
Therapeutic Advances in Respiratory Disease. 2022-07-11 - 6 citationsRelationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related...Dave Singh, Klaus F Rabe, Fernando J Martinez, Matthias Krüll, Martin Jenkins
Respiratory Medicine. 2022-06-01 - 9 citationsBenefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges:...Mona Bafadhel, Klaus F Rabe, Fernando J Martinez, Dave Singh, Patrick Darken
International Journal of Chronic Obstructive Pulmonary Disease. 2022-01-01
Authored Content
- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPDJune 2020
Grant Support
- Pathogenesis Of Nonpulmonary Organ Failure In ARDSNational Heart, Lung, And Blood Institute1991–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: